 PONTE VEDRA, Fla., Oct. 25, 2022 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace NasdaqGS: TMCI, a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus commonly known as bunions, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in the following upcoming investor conferences. 